If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

The OvarianVax vaccine could revolutionize the way ovarian cancer is prevented, while a new ultrasound promises to detect the disease with 96% accuracy.

A laboratory hoping to develop a vaccine for ovarian cancer has been awarded funding. Scientists at the University of Oxford are creating OvarianVax, a vaccine which they hope will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

THE WORLD’S first vaccine combating ovarian cancer that’s being developed in the UK could “wipe out” the deadly disease, researchers say. Scientists at the University of

The hope is the jab could be given to all women preventatively on the NHS to eliminate the disease, which is the sixth most common cancer in women.

A few decades ago the idea of a cancer vaccine was science fiction’ – but it is now becoming more of a reality, says Dr Claire Bromley from Cancer Research UK

Experts hope the ovarian cancer jab could work in a similar way to the human papillomavirus (HPV) vaccine, which is on track to stamp out cervical cancer.

The first ovarian cancer vaccine is being developed, and creators and hopeful it could wipe out the disease. The UK is currently developing the world’s first vaccine for ovarian cancer at the University of Oxford.

The vaccines are still in early development, but if tests are successful, they could help prevent one of the most common forms of cancer for women.

What you need to know about breakthrough jab that could wipe out disease - There are around 7,500 new ovarian cancer cases in the UK every year